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SUPPLEMENTARY MATERIALS AND METHODS
Genetic targeting and viral transduction
Animal procedures were in accordance with UK Home Office regulations. Expression of ChR2 in OHNs was carried out and functionally confirmed as illustrated in Fig. S1 .
Briefly, high-titer (1.5*10 12 vg/ml) adeno-associated viral (AAV) constructs rAAV2/1.EF1a-DIO-hChR2(H134R)-EYFP.WPRE.hGH (Addgene  #20298; packaged at Vector Core, University of Pennsylvania) were stereotaxically injected into brains of orexin-Cre mice, bred in het-WT breeding pairs with C57BL/6 mice. 4-6 week-old male and female mice were anesthetized with isoflourane and head-fixed in a stereotaxic frame (David Kopf Instruments). In some experiments in Fig. 3A ,B,
we also used rAAV2/Ef1a-DIO-ChR2(E123T/T159C)-mcherry (3*10 12 vg/ml; Addgene #35510 packaged at Vector Core, University of Pennsylvania) with similar results (data from two AAVs were pooled in this figure).
A borosilicate glass pipette tip (20-40 µm diameter) was stereotaxically lowered into the lateral hypothalamus. Three injections (each 50 nl, delivered at 75 nl/min) were made into LH in each hemisphere (bregma: -1.3 to -1.4 mm; midline ±0.9 mm; dorsal surface: -5.30, -5.15, and -5.00 mm). The pipette was gently withdrawn 6 min after final injection. Injections of identical AAV constructs into the lateral hypothalamus of WT mice did not generate ChR2-eYFP expression in the lateral hypothalamus (n = 3 mice), confirming that ChR2 expression was specific to Cre-containing cells.
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Immunolabelling
We tested for specificity of transgene expression in orexin-Cre mice using immunohistochemistry. Orexin-Cre mice that had been previously injected with AAV containing ChR2-eYFP were terminally anesthetized and transcardially perfused with phosphate buffered saline containing 4 % PFA. Following postfixation brains were sectioned into 50 µm thick slices using a cryostat. Slices were stained using rabbit anti orexin-A (Phoenix Pharmaceutics, Inc., USA; 1:250) and mouse anti Crerecombinase (Millipore, USA; 1:500) antibodies. We used goat anti rabbit alexa 647
(1:500) and goat anti mouse alexa 488 (1:1000) from Invitrogen for fluorescent labelling.
To label HANs during whole-cell recordings, these were filled with 0.2 % biocytin (Tocris) that was added to the intracellular recording solution. Cells were kept in the whole-cell mode for a minimum of 20 min. After recovery for at least 20 min, the tissue was fixed in 4 % PBS overnight. Biocytin filled cells were labeled with rabbit anti adenosine deaminase (Chemicon; 1:250). Immunofluorescence was achieved using goat anti-rabbit Alexa 555 (Invitrogen; 1:1000) antibodies and streptavidin tagged with Cy2 (Invitrogen; 1:1000).
Images were taken using an Olympus BX61WI confocal microscope (Olympus FluoView v 2.1b software) in a dynamic range of 16 bit using a 25x water immersion objective (NA 1.05, Olympus). Cy2 was excited with an argon laser at 488 nm, and its fluorescence collected between 570 and 670 nm using a spectral detector (Olympus).
Alexa 555 was excited with a diode-pumped solid-state (DPSS) laser at 559 nm, and fluorescence emission collected at 570-670 nm using a spectral detector (Olympus).
When more than one fluorophore was detected, the sequential "between-lines" scanning mode of the microscope was used to achieve optimal separation of fluorescent signals.
Photostimulation and electrophysiology
Coronal slices containing the tuberomammillary hypothalamic nucleus ( 
Analysis
Data were analysed with Minianalysis (Synaptosoft), Matlab (Mathworks) or Prism (Graphpad). Histamine neuron firing responses to optical orexin neuron stimulation were separated from baseline firing by subtracting the average baseline firing during 10 s prior to stimulation in each cell. In group data plots, results are presented as means ± sem of multiple experimental trials (1-2 trials were recorded per cell), except 5 where stated otherwise. Student's unpaired or paired t-test, or one or two-way ANOVA followed by Bonferroni or Newman-Keuls posthoc tests, were used for statistical hypothesis testing; the significance labels in the figures are *p < 0.05, **p < 0.01, ***p < 0.001, and p > 0.05 was taken as non-significant (ns).
Chemicals and solutions
ACSF was bubbled with 95% O 2 and 5% CO 2 and contained (in mM): 125 NaCl, 2. Na 2 Phosphocreatine, pH = 7.3 with KOH. Orexin/hypocretin receptors were blocked with either 10 µM TCS-OX2-29 ("TCS", an OHR2 receptor blocker), and/or 10 µM SB-334867 ("SB", an OHR1 blocker at this concentration). AMPA glutamate receptors were blocked with 10 µM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).
NMDA glutamate receptors were blocked with 50 µM (2R)-amino-5-phosphonovaleric acid (AP5). GABA A/C receptors were blocked with 50 µM picrotoxin (PiTX). For bath application of orexin/hypocretin, we used 300 nM orexin-A from Bachem. All other chemicals were from Sigma or Tocris.
6 Figure S1 . Studying functional transmission in orexin  histamine microcircuit (Illustration of methodological background to experiments in main Figures 1-3) .
A. Schematic of virally-delivered constructs used to transduce orexin-Cre neurons (OHNs) with ChR2 (top), after which OHN spikes routinely followed optical stimuli in brain slices (bottom, typical example of n = 10 cells).
B:
Schematic of experimental strategy for probing postsynaptic responses of histamine neurons (HANs) to OHN stimulation (top), and typical confocal images (bottom) of a HAN filled with biocytin (BC) and confirmed by post-recording immunocytochemistry to contain HAN marker adenosine deaminase (ADA, arrowheads, n = 3/3 cells). ChR2-eYFP fibers (shown in red pseudo-color) make close contact with HAN (arrows in bottom images). Scale bar, 10 µm.
